Effects of a Protocol of Hip Flexor Stretching on Chronic Mechanical, Non-specific LBP. (NCT06975345) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effects of a Protocol of Hip Flexor Stretching on Chronic Mechanical, Non-specific LBP.
Poland100 participantsStarted 2025-07-02
Plain-language summary
The goal of this clinical trial is to compare the effectiveness of a stretching, exercise and education protocol versus usual care in improving pain, function and disability in patients with non-specific mechanical chronic low back pain (CLBP). The research hypothesis is: A combination of hip flexors stretching, exercise and education is more effective than usual care to improve pain, function and disability in patients with CLBP.
Participants will be randomly allocated in one of the two treatment groups. Pain, function and disability will be assessed before starting treatment, after the end of the treatment and one month , three months and one year after the end of the treatment.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 18-75 years
* Medical diagnosis of chronic, mechanical, non-specific pain in the lumbar spine (M54, M51) - chronic low back pain.
* Obtaining written consent to conduct research
* Must be able to swallow tablets
Exclusion Criteria:
* Pregnancy
* Pacemaker
* Active cancer
* To consent to conduct research
* Difficulty communicating
* The presence of a metal plate in the head and metal screws in the body
* Condition after operations in the area of the lumbar spine
* Condition after fractures in the lumbar spine
* Contraindications to manual therapy or exercise
* Has participated in a lumbar spine exercise or manual therapy program in the last three months
* Present clear signs of having suffered a significant lumbar injury
* Inability to maintain standing or a supine or prone position
* No possibility to perform the stretching of hip flexors
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Numeric Pain Rating Scale (NPRS)
Timeframe: Baseline, to complete the treatments, on average 2 weeks, 1, 3 and 12 months after the end of treatment
Trial details
NCT IDNCT06975345
SponsorWroclaw University of Health and Sport Sciences